Handmade quality · Free shipping over $75 · Explore the atelier

JR-AB2-011 Catalog No.:M20491-C Cancer Drug Discovery and Development

SKU: 39775863590

4.0
USD100.00 USD123.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 26 - Jul 31

Description

Cancer Drug Discovery and Development

4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide

Brivanib alaninate is the alaninate ester of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity

H-1437 cells

JR-AB2-011 Catalog No.:M20491-C Cancer Drug Discovery and DevelopmentJR AB2 011 is a selective mTORC2 inhibitor with an IC50 value of 0. 36 M. JR AB2 011 inhibits mTORC2 activity by blocking Rictor mTOR association (Ki: 0. 19 M). JR AB2 011 has anti glioblastoma multiforme (GBM) properties. Product information CAS Number: 2411853 34 2 Molecular Weight: 398. 28 Formula: C17H14Cl2FN3OS Chemical Name: (2Z) N (3,4 dichlorophenyl) 2 [(4 fluorophenyl)imino] 5 methyl 1,3 thiazolidine 3 carboxamide Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products